The principle goal was to establish acceptable analytical targets by analyzing human hepatocyte incubation samples with superior-resolution mass spectrometry (HRMS) and to substantiate the outcomes in reliable urine specimens and to find out AB-FUBINACA's metabolic balance in human liver microsomes and in comparison hepatocyte and urine benefits wi